Chief Strategy Officer of Pulse Biosciences Mitchell Levinson Buys 24% More Shares

Investors who take an interest in Pulse Biosciences, Inc. (NASDAQ:PLSE) should definitely note that the Chief Strategy Officer, Mitchell Levinson, recently paid US$5.90 per share to buy US$105k worth of the stock. That's a very decent purchase to our minds and it grew their holding by a solid 24%.

Check out our latest analysis for Pulse Biosciences

The Last 12 Months Of Insider Transactions At Pulse Biosciences

In the last twelve months, the biggest single purchase by an insider was when Executive Chairman Robert Duggan bought US$65m worth of shares at a price of US$6.51 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$6.12). It's very possible they regret the purchase, but it's more likely they are bullish about the company. In our view, the price an insider pays for shares is very important. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.

While Pulse Biosciences insiders bought shares during the last year, they didn't sell. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Does Pulse Biosciences Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Pulse Biosciences insiders own about US$232m worth of shares (which is 68% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Do The Pulse Biosciences Insider Transactions Indicate?

It is good to see recent purchasing. And the longer term insider transactions also give us confidence. But we don't feel the same about the fact the company is making losses. When combined with notable insider ownership, these factors suggest Pulse Biosciences insiders are well aligned, and quite possibly think the share price is too low. Looks promising! So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. At Simply Wall St, we've found that Pulse Biosciences has 4 warning signs (2 are significant!) that deserve your attention before going any further with your analysis.

Of course Pulse Biosciences may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.